lincomycin- lincomycin injection
durvet, inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin 300 mg in 1 ml - anada #200-315, approved by f.d.a. lincomycin injectable brand of lincomycin hydrochloride injectable for intramuscular use in swine over 300 lbs. only swine antibiotic lincomycin injectable contains lincomycin hydrochloride, an antibiotic produced by sterptomyces lincolnensis var. lincolnensis, which is chemically distinct from all other clinically available antibiotics and is isolated as a white crystalline solid. indicated for the treatment of arthrits caused by susceptible organisms and for mycoplasma pneumonia. indications for swine lincomycin injectable is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. this includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci, erysipelothrix and mycoplasma spp. it is also indicated for the treatment of mycoplasma pneumonia. as with all drugs, the use of lincomycin injectable is contraindicated in animals previously found to be hyper
lincomycin s 50- lincomycin spectinomycin powder
aspen veterinary resources - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f), spectinomycin hydrochloride (unii: hwt06h303z) (spectinomycin - unii:93aki1u6qf) - directions for use indications and usage: for use in chickens up to 7 days of age as an aid in the control of: airsacculitis caused by either mycoplasma synoviae or mycoplasma gallisepticum susceptible to lincomycin-spectinomycin. complicated chronic respiratory disease (air sac infection) caused by escherichia coli and m. gallisepticum susceptible to lincomycin-spectinomycin.
lincomycin hydrochloride powder
quo vademus - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin 0.4 g in 1 g - broiler chickens: directions for use indication: lincomycin hydrochloride soluble powder is indicated for the control of necrotic enteritis caused by clostridium perfringens susceptible to lincomycin. dosage: administer at a dose rate of 64 mg of lincomycin per gallon of drinking water. treatment period: start medication as soon as the diagnosis of necrotic enteritis is determined. the drug should be administered for 7 consecutive days. administration: this packet will medicate 3000 gallons of drinking water providing 64 mg/gallon. note: after water medication is discontinued, a recommended control program for necrotic enteritis consists of feeding lincomycin premix at 2 grams lincomycin per ton of complete feed. swine: directions for use indication: lincomycin hydrochloride soluble powder is indicated for the treatment of swine dysentery (bloody scours). dosage: administer at a dose rate of 250 mg of lincomycin per gallon of drinking water. in clinical studies, this dose rate provided an average of
lincomycin- lincomycin hydrochloride injection, solution
general injectables and vaccines, inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - this drug is contraindicated in patients previously found to be hypersensitive to lincomycin or clindamycin.
lincomycin-spectinomycin water soluble powder- lincomycin-spectinomycin powder, for solution
huvepharma, inc - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f), spectinomycin hydrochloride (unii: hwt06h303z) (spectinomycin - unii:93aki1u6qf) - directions for use indications and usage: for use in chickens up to 7 days of age as an aid in the control of: airsacculitis caused by either mycoplasma synoviae or mycoplasma gallisepticum susceptible to lincomycin-spectinomycin. complicated chronic respiratory disease (air sac infection) caused by escherichia coli and m. gallisepticum susceptible to lincomycin-spectinomycin. warning: not for human use keep out of reach of children to report suspected adverse drug events, for technical assistance or to obtain a copy of the safety data sheet (sds), contact huvepharma, inc. at 1-877-994-4883 or www.huvepharma.us. for additional information about adverse drug experience reporting for animal drugs, contact fda at 1-888-fda-vets or http://www.fda.gov/reportanimalae.
lincomycin- lincomycin hydrochloride injection, solution
xgen pharmaceuticals djb, inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin 300 mg in 1 ml - lincomycin injection, usp is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of cdad, as described in the boxed warning , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. indicated surgical procedures should be performed in conjunction with antibacterial therapy. lincomycin injection may be administered concomitantly with other antimicrobial agents when indicated. lincomycin is not indicated in the treatment of minor bacterial infections or viral infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of lincomycin and other antibacterial drugs, lincomycin should be used only to treat or prevent infections that are proven or strongly suspected
lincomycin hydrochloride injection, solution lincomycin hydrochloride injection, solution
gland pharma limited - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin injection is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of cdad, as described in the boxed warning , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. indicated surgical procedures should be performed in conjunction with antibacterial therapy. lincomycin injection may be administered concomitantly with other antimicrobial agents when indicated. lincomycin injection is not indicated in the treatment of minor bacterial infections or viral infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of lincomycin injection and other antibacterial drugs, lincomycin injection should be used only to treat or prevent infections that are proven
lincomix 20- lincomycin hydrochloride granule
zoetis inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin 20 g in 0.453 kg - lincomix® 20 (lincomycin) type a medicated article 20 grams/lb for the control of necrotic enteritis caused or complicated by clostridium spp. or other organisms susceptible to lincomycin in broilers. for the treatment and control of swine dysentery, and the control of porcine proliferative enteropathies (ileitis) caused by lawsonia intracellularis . for reduction in the severity of the effects of respiratory disease associated with mycoplasma hyopneumoniae. each pound contains: active drug ingredient lincomycin ………………………………….20 grams (as lincomycin hydrochloride agricultural grade) inactive ingredients soybean hulls, #20 grind; light liquid paraffin, ph.eur. important: must be thoroughly mixed in feeds before use. store open bag in dry place to prevent caking. store at room temperature. approved by fda under nada # 097-505
linxmed-sp- lincomycin hydrochloride powder
bimeda, inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin 32 g in 80 g - swine: directions for use indications : linxmed-sp® soluble powder is indicated for the treatment of swine dysentery (bloody scours). dosage : administer at a dose rate of 250 mg of lincomycin per gallon of drinking water. in clinical studies, this dose rate provided an average of 3.8 mg of lincomycin per pound of body weight per day. treatment period: the drug should be administered for a minimum of 5 consecutive days beyond disappearance of symptoms (bloody stools) up to a maximum of 10 consecutive days. if water treatment is discontinued prior to this time, a lincomycin treatment program may be continued with lincomycin premix at 100 grams lincomycin per ton of complete feed as the sole ration according to label directions. administration: this packet will medicate 128 gallons of drinking water providing 250 mg/gallon. a dose of 3.8 mg lincomycin per pound of body weight may be maintained by medicating the drinking water at a concentration of 250
lincomycin- lincomycin injection
aspen veterinary resources, ltd. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin injectable is indcated fot he treatmen of infectious forms of arthritis caused by organisms sensitive to its activity. this includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci, erysipelothrix and mycoplasma ssp . it is also indicated for the treatment of mycoplasma pneumonia. as with all drugs, the use of lincomycin injectable is contraindicated in animals previously found to be hypersensitive to the drug.